{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:57Z","timestamp":1792787937511,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg","id":[{"id":"https:\/\/ror.org\/03vzbgh69","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02801-8","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:35:13Z","timestamp":1789634113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KMT9 drives T cell exclusion and dysfunction by promoting PMN-MDSCs infiltration and ARG1 expression in prostate cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Jon","family":"Pe\u00f1arando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominica","family":"Willmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Sum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Berlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas M.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Duteil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gratzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zeiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Greschik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Sch\u00fcle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2801_CR1","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1101\/gad.315739.118","volume":"32","author":"G Wang","year":"2018","unstructured":"Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and biology of prostate cancer. Genes Dev. 2018;32:1105\u201340.","journal-title":"Genes Dev"},{"key":"2801_CR2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.tem.2024.12.003","volume":"36","author":"L Brea","year":"2025","unstructured":"Brea L, Yu J. Tumor-intrinsic regulators of the immune-cold microenvironment of prostate cancer. Trends Endocrinol Metab. 2025;36:855\u201366.","journal-title":"Trends Endocrinol Metab"},{"key":"2801_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541:321\u201330.","journal-title":"Nature"},{"key":"2801_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nature14011","volume":"515","author":"RS Herbst","year":"2014","unstructured":"Herbst RS, et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature. 2014;515:563\u20137.","journal-title":"Nature"},{"key":"2801_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348:74\u201380.","journal-title":"Science"},{"key":"2801_CR6","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/JCI45817","volume":"122","author":"H Salmon","year":"2012","unstructured":"Salmon H, et al. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest. 2012;122:899\u2013910.","journal-title":"J Clin Invest"},{"key":"2801_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1135456","volume":"13","author":"S Bruni","year":"2023","unstructured":"Bruni S, Mercogliano MF, Mauro FL, Cordo Russo RI, Schillaci R. Cancer immune exclusion: breaking the barricade for a successful immunotherapy. Front Oncol. 2023;13:1135456.","journal-title":"Front Oncol"},{"key":"2801_CR8","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550\u20138.","journal-title":"Nat Med"},{"key":"2801_CR9","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1158\/0008-5472.CAN-19-2948","volume":"80","author":"HR Cha","year":"2020","unstructured":"Cha HR, Lee JH, Ponnazhagan S. Revisiting immunotherapy: a focus on prostate cancer. Cancer Res. 2020;80:1615\u201323.","journal-title":"Cancer Res"},{"key":"2801_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s43018-021-00227-3","volume":"2","author":"ZA Lopez-Bujanda","year":"2021","unstructured":"Lopez-Bujanda ZA, et al. Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression. Nat Cancer. 2021;2:803\u201318.","journal-title":"Nat Cancer"},{"key":"2801_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/2326-6066.CIR-17-0385","volume":"6","author":"E Jachetti","year":"2018","unstructured":"Jachetti E, et al. Cross-talk between myeloid-derived suppressor cells and mast cells mediates tumor-specific immunosuppression in prostate cancer. Cancer Immunol Res. 2018;6:552\u201365.","journal-title":"Cancer Immunol Res"},{"key":"2801_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41586-018-0266-0","volume":"559","author":"A Calcinotto","year":"2018","unstructured":"Calcinotto A, et al. IL-23 secreted by myeloid cells drives castration-resistant prostate cancer. Nature. 2018;559:363\u20139.","journal-title":"Nature"},{"key":"2801_CR13","doi-asserted-by":"publisher","unstructured":"Guo, C. et al. Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance. Nature. 2023. https:\/\/doi.org\/10.1038\/s41586-023-06696-z","DOI":"10.1038\/s41586-023-06696-z"},{"key":"2801_CR14","doi-asserted-by":"publisher","first-page":"19988","DOI":"10.1021\/acs.jmedchem.4c01429","volume":"67","author":"M Failla","year":"2024","unstructured":"Failla M, et al. Opportunities and challenges of arginase inhibitors in cancer: a medicinal chemistry perspective. J Med Chem. 2024;67:19988\u201320021.","journal-title":"J Med Chem"},{"key":"2801_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01657-y","volume":"21","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yi M, Niu M, Mei Q, Wu K. Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy. Mol Cancer. 2022;21:184.","journal-title":"Mol Cancer"},{"key":"2801_CR16","doi-asserted-by":"crossref","unstructured":"Teijeira, A. et al. CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity. Immunity. 2020;52:856\u2013871 e858.","DOI":"10.1016\/j.immuni.2020.03.001"},{"key":"2801_CR17","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s11739-023-03309-5","volume":"18","author":"S Sitaru","year":"2023","unstructured":"Sitaru S, Budke A, Bertini R, Sperandio M. Therapeutic inhibition of CXCR1\/2: where do we stand? Intern Emerg Med. 2023;18:1647\u201364.","journal-title":"Intern Emerg Med"},{"key":"2801_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2159-8290.CD-15-0224","volume":"6","author":"G Wang","year":"2016","unstructured":"Wang G, et al. Targeting YAP-dependent MDSC infiltration impairs tumor progression. Cancer Discov. 2016;6:80\u201395.","journal-title":"Cancer Discov"},{"key":"2801_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41594-019-0219-9","volume":"26","author":"E Metzger","year":"2019","unstructured":"Metzger E, et al. KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells. Nat Struct Mol Biol. 2019;26:361\u201371.","journal-title":"Nat Struct Mol Biol"},{"key":"2801_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41421-019-0121-y","volume":"5","author":"W Li","year":"2019","unstructured":"Li W, Shi Y, Zhang T, Ye J, Ding J. Structural insight into human N6amt1-Trm112 complex functioning as a protein methyltransferase. Cell Discov. 2019;5:51.","journal-title":"Cell Discov"},{"key":"2801_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41421-019-0119-5","volume":"5","author":"CB Woodcock","year":"2019","unstructured":"Woodcock CB, Yu D, Zhang X, Cheng X. Human HemK2\/KMT9\/N6AMT1 is an active protein methyltransferase, but does not act on DNA in vitro, in the presence of Trm112. Cell Discov. 2019;5:50.","journal-title":"Cell Discov"},{"key":"2801_CR22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/emboj\/21.4.769","volume":"21","author":"V Heurgue-Hamard","year":"2002","unstructured":"Heurgue-Hamard V, Champ S, Engstrom A, Ehrenberg M, Buckingham RH. The hemK gene in Escherichia coli encodes the N(5)-glutamine methyltransferase that modifies peptide release factors. EMBO J. 2002;21:769\u201378.","journal-title":"EMBO J"},{"key":"2801_CR23","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1128\/MCB.00218-10","volume":"30","author":"P Liu","year":"2010","unstructured":"Liu P, et al. Deficiency in a glutamine-specific methyltransferase for release factor causes mouse embryonic lethality. Mol Cell Biol. 2010;30:4245\u201353.","journal-title":"Mol Cell Biol"},{"key":"2801_CR24","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1073\/pnas.032488499","volume":"99","author":"K Nakahigashi","year":"2002","unstructured":"Nakahigashi K, et al. HemK, a class of protein methyl transferase with similarity to DNA methyl transferases, methylates polypeptide chain release factors, and hemK knockout induces defects in translational termination. Proc Natl Acad Sci U S A. 2002;99:1473\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2801_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1158\/0008-5472.CAN-21-1261","volume":"82","author":"C Berlin","year":"2022","unstructured":"Berlin C, et al. KMT9 controls sternness and growth of colorectal cancer. Cancer Res. 2022;82:210\u201320.","journal-title":"Cancer Res"},{"key":"2801_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-1141-2","volume":"20","author":"HM Baumert","year":"2020","unstructured":"Baumert HM, et al. Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell death. Cancer Cell Int. 2020;20:52.","journal-title":"Cancer Cell Int"},{"key":"2801_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nature03918","volume":"436","author":"Z Chen","year":"2005","unstructured":"Chen Z, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005;436:725\u201330.","journal-title":"Nature"},{"key":"2801_CR28","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1084\/jem.20171207","volume":"215","author":"M Parisotto","year":"2018","unstructured":"Parisotto M, et al. PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo. J Exp Med. 2018;215:1749\u201363.","journal-title":"J Exp Med"},{"key":"2801_CR29","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1128\/MCB.00090-14","volume":"34","author":"AJ Garcia","year":"2014","unstructured":"Garcia AJ, et al. Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression. Mol Cell Biol. 2014;34:2017\u201328.","journal-title":"Mol Cell Biol"},{"key":"2801_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02219-w","volume":"18","author":"VB Cetintas","year":"2020","unstructured":"Cetintas VB, Batada NN. Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment? J Transl Med. 2020;18:45.","journal-title":"J Transl Med"},{"key":"2801_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1593\/neo.07976","volume":"10","author":"LA Begley","year":"2008","unstructured":"Begley LA, et al. CXCL5 promotes prostate cancer progression. Neoplasia. 2008;10:244\u201354.","journal-title":"Neoplasia"},{"key":"2801_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/cjp2.160","volume":"6","author":"J Wen","year":"2020","unstructured":"Wen J, et al. Polymorphonuclear MDSCs are enriched in the stroma and expanded in metastases of prostate cancer. J Pathol Clin Res. 2020;6:171\u20137.","journal-title":"J Pathol Clin Res"},{"key":"2801_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","volume":"20","author":"S Jaillon","year":"2020","unstructured":"Jaillon S, et al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer. 2020;20:485\u2013503.","journal-title":"Nat Rev Cancer"},{"key":"2801_CR34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol. 2016;37:208\u201320.","journal-title":"Trends Immunol"},{"key":"2801_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01565","volume":"8","author":"J Dai","year":"2017","unstructured":"Dai J, Kumbhare A, Youssef D, McCall CE, El Gazzar M. Intracellular S100A9 promotes myeloid-derived suppressor cells during late sepsis. Front Immunol. 2017;8:1565.","journal-title":"Front Immunol"},{"key":"2801_CR36","first-page":"1805","volume":"46","author":"HD Bear","year":"1986","unstructured":"Bear HD. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens. Cancer Res. 1986;46:1805\u201312.","journal-title":"Cancer Res"},{"key":"2801_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10979-3","volume":"10","author":"M Czystowska-Kuzmicz","year":"2019","unstructured":"Czystowska-Kuzmicz M, et al. Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. Nat Commun. 2019;10:3000.","journal-title":"Nat Commun"},{"key":"2801_CR38","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443\u201354.","journal-title":"N Engl J Med"},{"key":"2801_CR39","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S1470-2045(14)70189-5","volume":"15","author":"ED Kwon","year":"2014","unstructured":"Kwon ED, et al. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2014;15:700\u201312.","journal-title":"Lancet Oncol"},{"key":"2801_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1200\/JCO.2016.69.1584","volume":"35","author":"TM Beer","year":"2017","unstructured":"Beer TM, et al. Randomized, double-blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients with metastatic chemotherapy-naive castration-resistant prostate cancer. J Clin Oncol. 2017;35:40\u20137.","journal-title":"J Clin Oncol"},{"key":"2801_CR41","doi-asserted-by":"publisher","unstructured":"Melo, C.M. et al. The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer. Int J Mol Sci. 2021;22 https:\/\/doi.org\/10.3390\/ijms22179550","DOI":"10.3390\/ijms22179550"},{"key":"2801_CR42","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1001294","volume":"363","author":"PW Kantoff","year":"2010","unstructured":"Kantoff PW, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363:411\u201322.","journal-title":"N Engl J Med"},{"key":"2801_CR43","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1158\/1078-0432.CCR-10-3126","volume":"17","author":"MA Cheever","year":"2011","unstructured":"Cheever MA, Higano CS. PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. Clin Cancer Res. 2011;17:3520\u20136.","journal-title":"Clin Cancer Res"},{"key":"2801_CR44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nrurol.2012.106","volume":"9","author":"D Karan","year":"2012","unstructured":"Karan D, Holzbeierlein JM, Van Veldhuizen P, Thrasher JB. Cancer immunotherapy: a paradigm shift for prostate cancer treatment. Nat Rev Urol. 2012;9:376\u201385.","journal-title":"Nat Rev Urol"},{"key":"2801_CR45","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jhep.2010.08.041","volume":"54","author":"DM Kuang","year":"2011","unstructured":"Kuang DM, et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol. 2011;54:948\u201355.","journal-title":"J Hepatol"},{"key":"2801_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng S, et al. Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies. Exp Hematol Oncol. 2024;13:80.","journal-title":"Exp Hematol Oncol"},{"key":"2801_CR47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41577-024-01098-2","volume":"25","author":"S Cane","year":"2025","unstructured":"Cane S, Geiger R, Bronte V. The roles of arginases and arginine in immunity. Nat Rev Immunol. 2025;25:266\u201384.","journal-title":"Nat Rev Immunol"},{"key":"2801_CR48","doi-asserted-by":"publisher","unstructured":"Menjivar, R.E. et al. Arginase 1 is a key driver of immune suppression in pancreatic cancer. Elife. 2023;12. https:\/\/doi.org\/10.7554\/eLife.80721","DOI":"10.7554\/eLife.80721"},{"key":"2801_CR49","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1956143","volume":"10","author":"A Sosnowska","year":"2021","unstructured":"Sosnowska A, et al. Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma. Oncoimmunology. 2021;10:1956143.","journal-title":"Oncoimmunology"},{"key":"2801_CR50","doi-asserted-by":"publisher","unstructured":"Su, X. et al. Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment. J Clin Invest. 2021;131. https:\/\/doi.org\/10.1172\/JCI145296","DOI":"10.1172\/JCI145296"},{"key":"2801_CR51","doi-asserted-by":"publisher","unstructured":"Sullivan, M.R. et al. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. Elife. 2019;8. https:\/\/doi.org\/10.7554\/eLife.44235","DOI":"10.7554\/eLife.44235"},{"key":"2801_CR52","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.4049\/jimmunol.1302167","volume":"193","author":"E Sahin","year":"2014","unstructured":"Sahin E, et al. Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses. J Immunol. 2014;193:1717\u201327.","journal-title":"J Immunol"},{"key":"2801_CR53","doi-asserted-by":"publisher","unstructured":"Matos, A., Carvalho, M., Bicho, M. & Ribeiro, R. Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression. Nutrients. 2021;13. https:\/\/doi.org\/10.3390\/nu13124503","DOI":"10.3390\/nu13124503"},{"key":"2801_CR54","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41568-022-00473-2","volume":"22","author":"CE Holbert","year":"2022","unstructured":"Holbert CE, Cullen MT, Casero RA Jr., Stewart TM. Polyamines in cancer: integrating organismal metabolism and antitumour immunity. Nat Rev Cancer. 2022;22:467\u201380.","journal-title":"Nat Rev Cancer"},{"key":"2801_CR55","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1158\/1535-7163.MCT-22-0721","volume":"22","author":"B Borek","year":"2023","unstructured":"Borek B, et al. Arginase 1\/2 inhibitor OATD-02: from discovery to first-in-man setup in cancer immunotherapy. Mol Cancer Ther. 2023;22:807\u201317.","journal-title":"Mol Cancer Ther"},{"key":"2801_CR56","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","volume":"5","author":"SM Steggerda","year":"2017","unstructured":"Steggerda SM, et al. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment. J Immunother Cancer. 2017;5:101.","journal-title":"J Immunother Cancer"},{"key":"2801_CR57","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2023-000249","volume":"3","author":"A Naing","year":"2024","unstructured":"Naing A, et al. First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours. BMJ Oncol. 2024;3:e000249.","journal-title":"BMJ Oncol"},{"key":"2801_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44:e71.","journal-title":"Nucleic Acids Res"},{"key":"2801_CR59","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173:400-416 e411.","journal-title":"Cell"},{"key":"2801_CR60","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature04020","volume":"437","author":"E Metzger","year":"2005","unstructured":"Metzger E, et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature. 2005;437:436\u20139.","journal-title":"Nature"},{"key":"2801_CR61","doi-asserted-by":"publisher","unstructured":"Crowell, P.D., Giafaglione, J.M., Hashimoto, T., Diaz, J.A. & Goldstein, A.S. Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture. J Vis Exp. 2019. https:\/\/doi.org\/10.3791\/60223","DOI":"10.3791\/60223"},{"key":"2801_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7:16878.","journal-title":"Sci Rep"},{"key":"2801_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25.","journal-title":"Genome Biol"},{"key":"2801_CR64","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s41590-018-0229-5","volume":"19","author":"S Patel","year":"2018","unstructured":"Patel S, et al. Unique pattern of neutrophil migration and function during tumor progression. Nat Immunol. 2018;19:1236\u201347.","journal-title":"Nat Immunol"},{"key":"2801_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26244-5","volume":"12","author":"JAE Payne","year":"2021","unstructured":"Payne JAE, et al. Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureus. Nat Commun. 2021;12:6157.","journal-title":"Nat Commun"},{"key":"2801_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/labinvest.2017.131","volume":"98","author":"P Bankhead","year":"2018","unstructured":"Bankhead P, et al. Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer. Lab Invest. 2018;98:15\u201326.","journal-title":"Lab Invest"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02801-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02801-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02801-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:22:39Z","timestamp":1789712559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02801-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2801"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02801-8","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Experimental mice were housed in the pathogen-free barrier facility of the University Medical Center Freiburg in accordance with institutional guidelines and all experiments were approved by the regional board (Regierungspr\u00e4sidium Freiburg, 35\u20139185.81\/G-19\/26).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"223"}}